General practice studies with combined pivampicillin/pivmecillinam (Miraxid).
D000293:Adolescent; D000328:Adult; D000368:Aged; D000560:Amdinocillin / Q000008:administration & dosage*; D000561:Amdinocillin Pivoxil / Q000008:administration & dosage* / Q000009:adverse effects; D000658:Amoxicillin / Q000008:administration & dosage / Q000009:adverse effects; D000667:Ampicillin / Q000031:analogs & derivatives*; D004338:Drug Combinations / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010033:Otitis Media / Q000188:drug therapy; D010917:Pivampicillin / Q000008:administration & dosage* / Q000009:adverse effects; D011897:Random Allocation; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012852:Sinusitis / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000008:administration & dosage; D014295:Trimethoprim / Q000008:administration & dosage; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014552:Urinary Tract Infections / Q000188:drug therapy
D004338:Drug Combinations; D010917:Pivampicillin; D000561:Amdinocillin Pivoxil; D000667:Ampicillin; D000658:Amoxicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; C046392:Miraxid; D014295:Trimethoprim; D013420:Sulfamethoxazole; D000560:Amdinocillin